Zachary S. Shell, APRN

Zachary Shell practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Zachary Shell's NPI, 1427648070, was assigned on January 19, 2021. Zachary Shell holds Nevada license 836273.

Zachary Shell's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Zachary Shell's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Zachary Shell is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Zachary Shell to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zachary Shell practices, 5 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Zachary Shell's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Zachary Shell is licensed in Nevada.

Dmand AI lists acute skin infection, arthritis, bursitis, chronic nasal allergies and joint or bone infection among the conditions Zachary Shell treats.

CMS data shows 508 Medicare services from Zachary Shell across 4 procedure codes in 2024, all of them office visits, for 257 Medicare patients. Medicare paid $26,612 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 257 Medicare patients who saw Zachary Shell in 2024. The largest group is 65 to 74, with 114 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Zachary Shell's median patient age at 72, with 49% women.

In 2024, Zachary Shell wrote 489 Medicare Part D claims for 185 patients. 98% of them were for generic drugs. CMS names the drug for 373 of them, across 9 drugs with 11 or more claims each, at $15,609 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Zachary Shell for performance year 2024, reported as part of a group. Zachary Shell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Zachary Shell as offering telehealth.

CMS Open Payments shows 10 general payments to Zachary Shell from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Aimmune Therapeutics, Inc. paid the most, $201.